Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Theodora Bejan-Angoulvan"'
Autor:
Jérémie Sellam, Laure Gossec, Pascal Claudepierre, Axel Finckh, Grégoire Cormier, Renaud Felten, Emmanuelle Dernis, Arnaud Constantin, Hubert Marotte, Philippe Goupille, Thierry Schaeverbeke, Athan Baillet, Anne Tournadre, Tristan Pascart, Maxime Breban, Valerie Devauchelle, Thierry Lequerre, Christian Jorgensen, Eric Lespessailles, Elisabeth Gervais, Daniel Wendling, Cédric Lukas, Corinne Miceli, Emilie Presles, Stephan Pavy, Jean-Hugues Salmon, Christian Marcelli, Olivier Brocq, Beatrice Bouvard, Benoit Le Goff, Florence Rancon, Theodora Bejan-Angoulvant, Elisa Dalix, Madjid Akrour, Liliane De Araujo, Christian H Roux
Publikováno v:
BMJ Open, Vol 14, Iss 9 (2024)
Introduction Axial spondyloarthritis (axSpA) is a chronic inflammatory disease characterised by inflammatory low back pain. Non-steroidal anti-inflammatory drugs (NSAIDs) are recommended as a first treatment in axSpA. In case of inadequate response t
Externí odkaz:
https://doaj.org/article/7b09aa494dc5437db5fef56602eb6bc8
Autor:
Philippe Goupille, Denis Mulleman, Jacqueline Detert, Theodora Bejan-Angoulvant, Johan Law-Wan, Marc-Antoine Sparfel, Sophie Derolez, Nicolas Azzopardi
Publikováno v:
RMD Open, Vol 7, Iss 3 (2021)
Externí odkaz:
https://doaj.org/article/8f130282d75248629bf81dcbeac3e11b
Publikováno v:
Frontiers in Neurology, Vol 11 (2020)
Background: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative condition characterized by the progressive loss of motor neurons. Patients usually die 3–5 years after diagnosis from respiratory failure. Several studies investigated the role
Externí odkaz:
https://doaj.org/article/0be8c7ef31d945b8be1ddecc9dafc6c2
Autor:
David Ternant, Olivier Le Tilly, Laurence Picon, Driffa Moussata, Christophe Passot, Theodora Bejan-Angoulvant, Céline Desvignes, Denis Mulleman, Philippe Goupille, Gilles Paintaud
Publikováno v:
Pharmaceutics, Vol 13, Iss 11, p 1821 (2021)
Infliximab is an anti-TNF-α monoclonal antibody approved in chronic inflammatory bowel diseases (IBD). This study aimed at providing an in-depth description of infliximab target-mediated pharmacokinetics in 133 IBD patients treated with 5 mg/kg infl
Externí odkaz:
https://doaj.org/article/e2d78037197449f6a4091c5a92ae7319
Autor:
Joachim Alexandre, Charles Dolladille, Laurent Douesnel, Jonaz Font, Rafal Dabrowski, Linda Shavit, Damien Legallois, Christian Funck‐Brentano, Laure Champ‐Rigot, Pierre Ollitrault, Farzin Beygui, Theodora Bejan‐Angoulvant, Jean‐Jacques Parienti, Paul Milliez
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 8, Iss 22 (2019)
Background Mineralocorticoid receptor antagonists (MRAs) have emerged as potential atrial fibrillation (AF) preventive therapy, but inconsistent results have been reported. We aimed to examine the effects of MRAs on AF occurrence and explore factors
Externí odkaz:
https://doaj.org/article/40a655bdaaf649b68dff766435a14605
GLUcose COntrol Safety & Efficacy in type 2 DIabetes, a systematic review and NETwork meta-analysis.
Autor:
Guillaume Grenet, Shams Ribault, Giao Bao Nguyen, Faustine Glais, Augustin Metge, Thomas Linet, Behrouz Kassai-Koupai, Catherine Cornu, Théodora Bejan-Angoulvant, Sylvie Erpeldinger, Rémy Boussageon, Aurore Gouraud, Fabrice Bonnet, Michel Cucherat, Philippe Moulin, François Gueyffier
Publikováno v:
PLoS ONE, Vol 14, Iss 6, p e0217701 (2019)
BackgroundThe last international consensus on the management of type 2 diabetes (T2D) recommends SGLT-2 inhibitors or GLP-1 agonists for patients with clinical cardiovascular (CV) disease; metformin remains the first-line glucose lowering medication.
Externí odkaz:
https://doaj.org/article/b80e052c1b1248caae71b05d7b6683f6
Autor:
Hai-Ha Le, Chadia El-Khatib, Margaux Mombled, Frédéric Guitarian, Muaamar Al-Gobari, Mor Fall, Perrine Janiaud, Ivanny Marchant, Michel Cucherat, Théodora Bejan-Angoulvant, François Gueyffier
Publikováno v:
PLoS ONE, Vol 11, Iss 2, p e0145958 (2016)
BACKGROUND AND OBJECTIVES:Sudden cardiac death (SCD) is a severe burden of modern medicine. Aldosterone antagonist is publicized as effective in reducing mortality in patients with heart failure (HF) or post myocardial infarction (MI). Our study aime
Externí odkaz:
https://doaj.org/article/9a0cc959490f4133b98d66cd0ec06233
Autor:
Rémy Boussageon, Irène Supper, Theodora Bejan-Angoulvant, Nadir Kellou, Michel Cucherat, Jean-Pierre Boissel, Behrouz Kassai, Alain Moreau, François Gueyffier, Catherine Cornu
Publikováno v:
PLoS Medicine, Vol 9, Iss 4, p e1001204 (2012)
BackgroundThe UK Prospective Diabetes Study showed that metformin decreases mortality compared to diet alone in overweight patients with type 2 diabetes mellitus. Since then, it has been the first-line treatment in overweight patients with type 2 dia
Externí odkaz:
https://doaj.org/article/099e18ead147466e9febdcd0e87c4740
Autor:
Ivanny Marchant, Patrice Nony, Michel Cucherat, Jean-Pierre Boissel, S Randall Thomas, Theodora Bejan-Angoulvant, Alexandra Laugerotte, Riad Kahoul, François Gueyffier
Publikováno v:
PLoS ONE, Vol 6, Iss 3, p e17508 (2011)
BackgroundThe prediction of the public health impact of a preventive strategy provides valuable support for decision-making. International guidelines for hypertension management have introduced the level of absolute cardiovascular risk in the definit
Externí odkaz:
https://doaj.org/article/b9d2b9a614dc4ba0a9a553f1dcc4345c
Autor:
Philippe Chevalier, France Cadi, Alina Scridon, Nicolas Girerd, Theodora Bejan-Angoulvan, Elodie Morel, Isabelle Jaisson Hot, Sylvie Di Filippo, Christell Ganne, Cyrille Colin
Publikováno v:
Circulation: Arrhythmia and Electrophysiology. 6:185-190
Background— Therapeutic management of asymptomatic patients with a Wolff–Parkinson–White (WPW) pattern is controversial. We compared the risk:benefit ratios between prophylactic radiofrequency ablation and no treatment in asymptomatic patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a5e765caf866e64f81a4f88433f3206
https://doi.org/10.1161/circep.112.970459
https://doi.org/10.1161/circep.112.970459